Abortion Information - October 12, 2008

Abortion Pill Curbs Breast Cancer Gene

November 30, 2006 - Topics abortion, breast cancer, cancer, stress and hospital
Scientists have found that the abortion drug RU-486 is able to curb tumors in mice bred with a breast cancer gene.

The experiment does not espouse using the drug this way but shows how the breast cancer gene BRCA1 functions by developing a hormone called progesterone which RU-486 blocks

read more >>

Report: Almost Half Of US Abortions Are Repeats

November 21, 2006 - Topics abortion, senior, women, child and research
Almost half of all US women who had abortions in 2002 reported to having previous abortions, the nonprofit Alan Guttmacher Institute found.

Women who had more than one abortion tended to be over the age of 30, had a large family, and were low income. Most of them were also using contraceptives at the time

read more >>

Study: Spruced Sex Ed Not Effective In UK

November 20, 2006 - Topics sex, study, child, pregnancy and abortion
A study found that while enhanced sex education programs are preferred by teachers and students, they did not affect pregnancy and abortion rates in UK schools.

Officials said there are many factors that come into play when it comes to preventing teen pregnancy and increasing education. Sex education is only one part of that. Parents have been found to have a large influence when it comes early pregnancy. Officials encourage parents to talk to their children more about sex

read more >>

Plan B Approval Said To Be Near

August 24, 2006 - Topics plan b, sex, birth control, pregnancy and abortion
According to sources, the Food and Drug Administration will approve an application, probably on Thursday, that would make the contraceptive Plan B available over the counter to women aged 18 or older.

Although Barr Labs is yet to receive approval on the "morning-after pill," sources say that they have been told that expansion of the drug would be imminent

read more >>

FDA Finds Agreement On Wider Sales Of Next-Day Pill

August 9, 2006 - Topics fda, birth control, food, prescription and women
Drug regulators and maker of a new contraceptive pill have agreed on a plan that would put the morning-after pill on the list of over-the-counter medicines within weeks. Barr Labs, the manufacturer of the new birth control pill, Plan B, said that it would resubmit a second application and Susan Bro, spokeswoman for the Food and Drug Administration said that the FDA would respond quickly.

The FDA has put off plan B in what critics believe was a move driven by political considerations

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use